摘要
目的探讨焦点解决短期治疗(SFBT)合用帕罗西汀(赛乐特)对社交恐惧症的临床疗效。方法将符合CCMD-3诊断标准的40例社交恐惧症患者,随机分为实验组(SFBT合用赛乐特)和对照组(单用赛乐特),在治疗前后及随防半年后采用社交回避及苦恼(SAD)量表评定其疗效。结果两组在疗后8周及随访半年后社交回避及苦恼(SAD)量表分比较有显著性差异。实验组评分显著低于对照组(P<0.01).两组均无严重的药物反应,因无疗效和不良反应导致的脱落率两组差异无显著性。(P>0.05)结论SFBT合用赛乐特和单用赛乐特对社交恐惧症均有疗效,且前者疗效更佳。
Objective： To evaluate the effect of solution - focused brief therapy（SFBT） combined with paroxetine in treatment of social phobia. Methods： 40 paitents who met CCMD - 3 criteria for social phobia were randomly assigned into experiment group （ SFBT plus paroxetine, n = 19 ） and control group （ paroxefine only,n = 18）. Before and after treatment , and followed up for half a year, the patients were assessed three times with SAD Scale. Results：After eight weeks treatment and half a year＇s follow - up, the score of SAD Scale showed significant difference. The score of SFBT group was significantly lower than that of the Paroxetine treatment group（P 〈0.01 ）. Both group had no serious side effects. There was no difference in dropout rate due to less efficacy and side effects. Conclusion： SFBT combined with paroxetine and paroxetine only have significant efficacy in the treatment of social phobia, and SFBT combined with paroxetine has better effect than paroxetine alone.
出处
《上海精神医学》
2006年第6期330-332,共3页
Shanghai Archives of Psychiatry
关键词
社交恐惧症
焦点解决短期治疗
赛乐特
Social phobia disorder Solution -focused brief therapy Paroxetine
